Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CanCore Concepts is a specialized biotechnology and technology licensing company focused on the cannabis and cannabinoid industry. The company is best known as the creator and parent of 'The Clear', which was the first brand to introduce distilled cannabis concentrates to the market. CanCore Concepts provides proprietary extraction, purification, and molecular distillation technologies to partners, enabling the production of high-purity, consistent cannabinoid products. Their business model centers on intellectual property licensing and providing turnkey manufacturing solutions for pharmaceutical-grade cannabis derivatives. The company's innovations focus on removing impurities and isolating specific cannabinoids for medical and therapeutic applications. By standardizing extraction processes, CanCore Concepts aims to provide reliable delivery systems for cannabinoid-based therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CanCore Concepts.